BerGenBio dispute resolved

February 28. 2019

BerGenBio ASA (OSE:BGBIO) has informed that the six months long arbitration with Rigel regarding the licensing agreement has been resolved. This news and the content of the settlement is very positive for the Bergen based company listed on the Oslo Stock Exchange.

 

Read more